Prognosis factors analysis of patients with malignant solitary pulmonary nodules

  • Yu-qing OUYANG ,
  • Lian-fang NI ,
  • Xin-min LIU
Expand
  • Department of Geriatrics, Peking University First Hospital, Beijing 100034, China

Received date: 2017-11-13

  Online published: 2020-02-20

Abstract

Objective: To explore the prognosis factors that influence the postoperative survival rate in patients with malignant solitary pulmonary nodules and to provide a reference for the prognosis risk stratification of early lung cancer patients. Methods: In this study, we retrospectively reviewed 172 patients who were admitted to Peking University First Hospital from April 2006 to December 2013. All cases were radiologically defined as solitary pulmonary nodule and were pathologically confirmed to be stage Ⅰa non-small cell lung cancer after surgical procedure. The patients’ clinical and follow-up data were summarized and analyzed. The relevance between survival time and factors that may affect patients’ prognosis was evaluated, which included gender, age, clinical symptoms, smoking history, comorbidity index, tumor biomarkers, nodule type, type of surgery, nodule location, nodule histopathological type, nodule size, histopathological differentiation grade, proliferating cell nuclear antigen Ki-67 expression level and epidermal growth factor receptor (EGFR) gene mutation. Kaplan-Meier survival analysis, Cox univariant and multivariant regression analysis were conducted to evaluate the factors affecting prognosis. Results: The 3-year overall survival rate of the atients with malignant solitary pulmonary nodules was 93.6%, and the 5-year overall survival rate was 89.8%. Kaplan-Meier survival analysis and Cox univariant regression analysis showed that the overall survival rate of the male patients was significantly lower than that of the female patients. In addition, the elderly patients with histopathology characterized as high Ki-67 proliferation index were also associated with the worse overall survival (P<0.05). Cox multivariant regression analysis demonstrated that age more than 65 years as well as the high Ki-67 expression level were independent risk factors for overall survival in patients with malignant solitary pulmonary nodules (age: P=0.023, HR=3.531, 95%CI 1.190-10.472; Ki-67: P=0.004, HR=1.021, 95%CI 1.007-1.035). Conclusion: For patients with malignant solitary pulmonary nodules, with pathological defined as stage Ⅰa non-small cell lung cancer, age, gender and Ki-67 expression levels might be important prognostic factors. Comprehensive consideration of Ki-67 proliferation index and clinical pathological features may help to stratify the prognosis more accurately and guide the selection of appropriate therapeutic strategies, which needs to be verified by multi-center studies.

Cite this article

Yu-qing OUYANG , Lian-fang NI , Xin-min LIU . Prognosis factors analysis of patients with malignant solitary pulmonary nodules[J]. Journal of Peking University(Health Sciences), 2020 , 52(1) : 158 -162 . DOI: 10.19723/j.issn.1671-167X.2020.01.025

References

[1] Al-Ameri A, Malhotra P, Thygesen H , et al. Risk of malignancy in pulmonary nodules: a validation study of four prediction models[J]. Lung Cancer, 2015,89(1):27-30.
[2] Perandini S, Soardi GA, Motton M , et al. Solid pulmonary nodule risk assessment and decision analysis: comparison of four prediction models in 285 cases[J]. Eur Radiol, 2016,26(9):3071-3076.
[3] 何权瀛, 高莹慧 . 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志, 2009,32(1):56.
[4] Higuchi M, Yaginuma H, Yonechi A , et al. Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer[J]. J Cardiothorac Surg, 2014,9:88.
[5] Khullar OV, Liu Y, Gillespie T , et al. Survival after sublobar resection versus lobectomy for clinical stage Ⅰa lung cancer: an analysis from the national cancer data base[J]. J Thorac Oncol, 2015,10(11):1625-1633.
[6] Wang BY, Huang JY, Cheng CY , et al. Lung cancer and prognosis in taiwan: a population-based cancer registry[J]. J Thorac Oncol, 2013,8(9):1128-1135.
[7] Yoshida Y, Murayama T, Sato Y , et al. Gender differences in long-term survival after surgery for non-small cell lung cancer[J]. Thorac Cardiovasc Surg, 2016,64(6):507-514.
[8] Ryu JS, Choi CM, Yang SC , et al. Prognostic effect of age on survival of patients with stage I adenocarcinoma of the lung[J]. Tumori, 2012,98(1):99-104.
[9] Dowsett M, Nielsen TO, A’Hern R , et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast cancer working group[J]. J Natl Cancer Inst, 2011,103(22):1656-1664.
[10] Luo Y, Ren F, Liu Y , et al. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis[J]. Int J Clin Exp Med, 2015,8(7):10235-10247.
[11] Pyo JS, Kang G, Sohn JH . Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis[J]. Int J Biol Markers, 2016,31(2):e204-e210.
[12] Ahn HK, Jung M, Ha SY , et al. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer[J]. Tumour Biol, 2014,35(6):5735-5740.
[13] Sofocleous CT, Garg SK, Cohen P , et al. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation[J]. Ann Surg Oncol, 2013,20(Suppl 3):S676-S683.
[14] Wen S, Zhou W, Li CM , et al. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies[J]. BMC Cancer, 2015,15:520.
Outlines

/